Xinyong Liu was born in 1963 in Qingdao, Shandong province, China. He received his B.S. and M.S. degrees from School of Pharmaceutical Sciences, Shandong University, in 1984 and in 1991, respectively. From 1997 to 1999, he worked at Instituto de Quimica Medica (CSIC) in Spain as a Senior Visiting Scholar. He obtained his Ph.D. degree from Shandong University in 2004. He serves currently a distinguished professor, a Designated Ph.D. Advisor, Director of the Institute of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University. His research work is partly engaged in rational drug design, synthesis, and bioevaluation of a variety of molecules targeted at the specific enzymes and receptors. At present time, his research interests are mainly focused on the design and synthesis of novel anti-HIV agents based on the mechanism of drug action and computer-assisted drug design, such as HIV-1 (non-)nucleoside reverse transcriptase inhibitors, HIV-1 transactivation inhibitors based on HIV-1 Tat-TAR interaction, and Rev-RRE interaction in the viral transcription step. His second ongoing program is total synthesis and structural modifications of some natural products from Chinese Traditional Medicine active in cerebro- and cardiovascular biology. He has contributed to about 150 scientific publications and patents as well as many monographs.
Biography Updated on 12 March 2012